387 related articles for article (PubMed ID: 29859057)
1. Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?
Macfarlane A; Greenhalgh T
BMC Pregnancy Childbirth; 2018 Jun; 18(1):200. PubMed ID: 29859057
[TBL] [Abstract][Full Text] [Related]
2. 'Conceivably Neglected' - Are prescribers sufficiently aware of the risks of prescribing sodium valproate to women with mental illness?
Perera C; Patterson S; Bruxner G
Australas Psychiatry; 2019 Apr; 27(2):125-128. PubMed ID: 30763123
[TBL] [Abstract][Full Text] [Related]
3. A UK clinical audit addressing the quality of prescribing of sodium valproate for bipolar disorder in women of childbearing age.
Paton C; Cookson J; Ferrier IN; Bhatti S; Fagan E; Barnes TRE
BMJ Open; 2018 Apr; 8(4):e020450. PubMed ID: 29654033
[TBL] [Abstract][Full Text] [Related]
4. Preventive recommendations on the use of valproic acid in pregnant or gestational women to be very present.
García-Portilla MP; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(3):129-133. PubMed ID: 28688547
[No Abstract] [Full Text] [Related]
5. [Caution and warning: About valproate and pregnancy].
Masson M; Huberfeld G; Richa S; Henry C; Gaillard R
Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894
[No Abstract] [Full Text] [Related]
6. Sodium valproate prescription to women of childbearing age in a New Zealand inpatient psychiatric unit.
Goldspink R; Pumipi T; Dey S; Menkes DB
Australas Psychiatry; 2020 Oct; 28(5):555-558. PubMed ID: 32586113
[TBL] [Abstract][Full Text] [Related]
7. Valproate prescription to women of childbearing age in English primary care: repeated cross-sectional analyses and retrospective cohort study.
Gaudio M; Konstantara E; Joy M; van Vlymen J; de Lusignan S
BMC Pregnancy Childbirth; 2022 Jan; 22(1):73. PubMed ID: 35086478
[TBL] [Abstract][Full Text] [Related]
8. [Prescribing valproate to girls and women of childbearing age in Germany : Analysis of trends based on claims data].
Wentzell N; Haug U; Schink T; Engel S; Liebentraut J; Linder R; Onken M; Schaefer C; Dathe K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Aug; 61(8):1022-1029. PubMed ID: 29922910
[TBL] [Abstract][Full Text] [Related]
9. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
Tomson T; Perucca E; Battino D
Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
[TBL] [Abstract][Full Text] [Related]
10. Prescription of Sodium Valproate as a Mood Stabiliser in Pregnancy.
Womersley K
Psychiatr Danub; 2017 Sep; 29(Suppl 3):679-684. PubMed ID: 28953852
[TBL] [Abstract][Full Text] [Related]
11. Valproate in the treatment of epilepsy in girls and women of childbearing potential.
Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E
Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171
[TBL] [Abstract][Full Text] [Related]
12. France bans sodium valproate use in case of pregnancy.
Casassus B
Lancet; 2017 Jul; 390(10091):217. PubMed ID: 28721869
[No Abstract] [Full Text] [Related]
13. [French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].
Samalin L; Arnould A; Boudieu L; Henry C; Haffen E; Drapier D; Anmella G; Pacchiarotti I; Vieta E; Belzeaux R; Llorca PM
Encephale; 2022 Dec; 48(6):624-631. PubMed ID: 36257849
[TBL] [Abstract][Full Text] [Related]
14. Sodium valproate and the fetus: a case study and review of the literature.
Smith J; Whitehall J
Neonatal Netw; 2009; 28(6):363-7. PubMed ID: 19892633
[TBL] [Abstract][Full Text] [Related]
15. Weighing the risks of valproate in women who could become pregnant.
Angus-Leppan H; Liu RSN
BMJ; 2018 Apr; 361():k1596. PubMed ID: 29669717
[No Abstract] [Full Text] [Related]
16. Valproate: life-saving, life-changing.
Thomas RH
Clin Med (Lond); 2018 Apr; 18(Suppl 2):s1-s8. PubMed ID: 29700085
[TBL] [Abstract][Full Text] [Related]
17. Valproate in Pregnancy: Recent Research and Regulatory Responses.
Andrade C
J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961
[TBL] [Abstract][Full Text] [Related]
18. Should women of childbearing potential be prescribed valproate? a call to action.
Balon R; Riba M
J Clin Psychiatry; 2016 Apr; 77(4):525-6. PubMed ID: 27137420
[TBL] [Abstract][Full Text] [Related]
19. Valproate and neuroendocrine changes in relation to women treated for epilepsy and bipolar disorder: a review.
Reynolds MF; Sisk EC; Rasgon NL
Curr Med Chem; 2007; 14(26):2799-812. PubMed ID: 18045126
[TBL] [Abstract][Full Text] [Related]
20. Valproate Teratogenicity: A Moving Target.
Gruppuso PA; Ahmed R; Adashi EY
Obstet Gynecol; 2022 Sep; 140(3):408-411. PubMed ID: 35926210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
